Participants List from Academia
Untitled Document
Kansas State University, USA
Deakin University, Australia
University of Texas, USA
University of North Carolina, USA
DRDO, Ministry of Defence, India
Anderson Cancer Center, USA
University of Texas, USA
Weill Medical College of Cornell University, USA
University Feinberg School of Medicine, USA
McGill University, USA
Purdue University, USA
The South Western Medical Center, USA
Kunming Medical College, China
Banaras Hindu University, India
University of Washington, USA
Istanbul Bilim University, Turkey
Georgetown University School of Medicine, USA
Louisiana state University, USA
Royal Victoria Hospital, USA
University Hospital Ulm, Germany
Universita degli Studi di Milano, Italy
San Diego Regenerative Medicine Institute & Xcelthera, San Diego, USA
Queensland University of Technology, Australia
Zagazig University, Egypt
Seoul National University, South Korea
Kansas State University, USA
MD Anderson Cancer Center, USA
Australian Institute of Physics, USA
St. Mary’s University of MN , USA
Tulane Cancer Center , USA
TVanderbilt University Medical Center , USA
University Hospital Ulm , Germany
Emory University School of Medicine , USA
University of Texas , USA
Purdue University , USA
San Diego Regenerative Medicine Institute & Xcelthera , USA
Queensland University of Technology, Australia
Deakin University, Australia
University of Pavia, Italy
Bharathiar University, India
Universidad Autonoma de Nuevo Leon, Mexico
Nelson Mandela University, South Africa
Seoul National University, South Korea
Universita degli Studi di Milano, Italy
Zagazig University, Egypt
Tata Memorial Hospital, India
Kaohsiung Medical University, Taiwan
Children’s Hospital Bambino Gesu , Italy
Tanta University , Egypt
The Weizmann Institute , Israel
Tehran university , Iran
Participants List From Business
Untitled Document
Cell Therapy Group, USA
Bioheart Inc., USA
Cellectis Stem Cells, Sweden
Cord Blood Registry Inc., USA
Reliance Life Sciences, India
Biospherix., USA
Hemo Genix, Inc, USA
Bioheart Inc, USA
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Women's Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddy's labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST), India
Novartis Campus, Austria
Upcoming Conferences
International Conference on Emerging Cell Therapies, will be organized around the theme "Evolving Technology in Cell Therapy and its Future Perspectives" .
Cell Therapy-2012 is comprised of 9 tracks and 56 sessions designed to offer comprehensive sessions that address current issues in Emerging Cell Therapies.
Submit your abstract to any of the following tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Renowned Speakers
Samir A. Farghaly
Weill Medical College of Cornell University, USA
Kapil Bharti
National Institutes of Health, USA
Tarek El-Bialy
University of Alberta, Canada
Kurt C Gunter
International Society for Cellular Therapy, Canada
David T. Harris
CSO, Cord Blood Registry Inc., USA
Ivan Rich
CEO of HemoGenix Inc., USA
Madhusudan V. Peshwa
MaxCyte Inc., , USA
Deryl Troyer
Kansas State University, USA
Lee Buckler
Cell Therapy Group, USA
Jagat R Kanwar
Deakin University, Australia
Kristin Comella
Bioheart Inc., USA
Christian X. Andersson
Cellectis Stem Cells, Sweden
John M. Tomich
Kansas State University, USA
Graeme Melville
St George Hospital, Australia
Vasiliy Galat
University Feinberg School of Medicine, USA
Prakash S. Bisen
DRDO, Ministry of Defence, India
Kumudha Balakrishnan
University of Texas, USA
Gary Guishan Xiao
Genomics & Functional
Proteomics Laboratories, USA
Nicolas Wickens
Nelson Mandela University, South Africa
Zelig Eshhar
The Weizmann Institute of Science, Israel
Ramin Lotfi
University Hospital Ulm, Germany
Nady Celine Golestaneh
Georgetown University School of Medicine, USA
Morayma Reyes
University of Washington, USA
Track 1: Cell Therapy- Potential Applications
Track 1-1
Molecular therapy
Track 1-2
Ocular therapy
Track 1-3
Neuro therapy for neurological diseases
Track 1-4
Cardiac cell therapy
Track 1-5
Immunotherapy and its applications
Track 1-6
Celltherapies for renal failure
Track 2: Stem Cell Therapies
Track 2-1
Molecular basis of pluripotency
Track 2-2
Bone marrow stem cells as therapy
Track 2-3
Current views of the embryonic and neural stem cells
Track 2-4
Stem cell therapy for genetic disorders
Track 2-5
Targeting stem cells for therapeutic benefits
Track 2-6
Transplantation technologies in stem cell therapy
Track 3: Cellular Therapies
Track 3-1
Cell replacement verses molecular repair
Track 3-2
Potential uses of defined cell populations
Track 3-3
Reprogramming cell fate
Track 3-4
Role of molecular markers in therapies
Track 3-5
Target tissues and routes of delivery
Track 3-6
Causes of regenerative failure
Track 4: Cancer Therapies
Track 4-1
Stem cells & cancer treatments
Track 4-2
Characteristics of cancer cells
Track 4-3
Cell cycle and oncology
Track 4-4
Modern approaches in molecular cancer therapeutics
Track 4-5
Genomics & cancer drug resistance
Track 4-6
Targeted cancer therapy
Track 4-7
Genetically engineered cancer vaccines
Track 4-8
Challenges & risks of cancer gene therapy
Track 5: Clinical Trials & Research in Cell Therapies
Track 5-1
Principles of gene therapy & clinical gene therapy
Track 5-2
Animal & human trials of engineered tissues
Track 5-3
Emerging clinical aspects of stem cell therapy
Track 5-4
Pharmacogenomics in cell therapy
Track 5-5
Clinical trial design and analysis
Track 5-6
Alternative lab models for cell therapy applications
Track 6: Nanotechnology in Cell Therapies
Track 6-1
Nano methods to target cancer cells
Track 6-2
Nano-microfluidics in cell therapy
Track 6-3
Nano materials and nano engineering
Track 6-4
Pros and cons of molecular manufacturing
Track 6-5
Nanovaccines
Track 7: Bioengineering in Cell Therapeutics
Track 7-1
Biomedical engineering
Track 7-2
Developing new probes for tissue targeting
Track 7-3
Therapeutic bioengineering
Track 7-4
Cellular mechanobiology
Track 7-5
Current understanding and challenges in bioprocessing
Track 7-6
Bioengineering for medical diagnostics and imaging
Track 8: Regulatory & Ethical Issues of Cell Therapy
Track 8-1
Commercialisation strategy
Track 8-2
Evolving regulatory requirements
Track 8-3
Risks and cost involved in stem cell maintenance
Track 8-4
Ethics involved in human stem cells
Track 8-5
Logistics in preparing lab models for cell therapy applications
Track 8-6
Manufacturing of cell therapy products and marketing guidelines
Track 8-7
Databases, industry news, published reports
Track 8-8
FDA & EMA guidelines
Track 9: Current Research & Future Perspectives on Cell Therapy
Track 9-1
Xenotransplantation
Track 9-2
Innovative therapeutic technologies
Track 9-3
Applications of cell therapy- from bench to bedside
Track 9-4
Cell therapy in future medicine
Track 9-5
Application of thermocycles in cell therapy